Source:http://linkedlifedata.com/resource/pubmed/id/16181731
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-7-3
|
pubmed:abstractText |
The activities of insulin-like growth factors (IGFs) in regulating cell proliferation, differentiation, and apoptosis are modulated by a family of high-affinity specific IGF-binding proteins (IGFBPs), IGFBP-3 being the most abundant in circulation. Down-regulation of IGFBP-3 has been shown to be associated with a shorter disease-specific survival probability in early non-small-cell lung cancer (NSCLC). We examined the prognostic role of IGFBP-3 protein expression loss in 34 squamous cell carcinomas (SCC) of the tongue (stages II-IV) and 30 premalignant lesions of the oral cavity and the larynx. Reduced IGFBP-3 expression was found in 11 (32%) of 34 tongue SCC cases, and was associated with significantly shorter disease-specific and disease-free survival (P=0.0002 and <0.0001 by Log-rank test). In premalignant lesions, IGFBP3 loss was found in 8 (27%) of 30 cases without significant association with cancer-free survival. Therefore, down-regulation of IGFBP-3 is an early event during head and neck carcinogenesis, that bears an adverse prognostic significance in tongue cancer and could serve as both a marker of aggressive disease and target for intervention.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0304-3835
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
239
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
136-43
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16181731-Aged,
pubmed-meshheading:16181731-Aged, 80 and over,
pubmed-meshheading:16181731-Carcinoma, Squamous Cell,
pubmed-meshheading:16181731-Down-Regulation,
pubmed-meshheading:16181731-Female,
pubmed-meshheading:16181731-Humans,
pubmed-meshheading:16181731-Insulin-Like Growth Factor Binding Protein 3,
pubmed-meshheading:16181731-Laryngeal Neoplasms,
pubmed-meshheading:16181731-Male,
pubmed-meshheading:16181731-Middle Aged,
pubmed-meshheading:16181731-Mouth Neoplasms,
pubmed-meshheading:16181731-Neoplasm Staging,
pubmed-meshheading:16181731-Prognosis,
pubmed-meshheading:16181731-Survival Rate,
pubmed-meshheading:16181731-Tongue Neoplasms
|
pubmed:year |
2006
|
pubmed:articleTitle |
The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis.
|
pubmed:affiliation |
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. vpapadim@mdanderson.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|